Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Approach to Quick Lead Optimization Including Physicochemical and ADME Profiling Pranas Japertas, Director, ACD Labs, Speaking at Medchem Europe 2011.
Preclinical Drug Safety: High Quality Data obtained with a New Automated Patch Clamp Platform Olaf Scheel, CSO, Cytocentrics AG speaking at Pharma Outsourcing Congress 2011
In a Virtual World, Where Are the Walls of the House? The New Outsourcing Katya Tsaioun, President, Apredica speaking at Pharma Outsourcing Congress 2011
Voltage-Gated Sodium Channel Activators with Differing Efficacies Stimulate Neurite Outgrowth in Cerebrocortical Neurons Thomas Murray, Professor and Chair, Creighton University School of Medicine, speaking at Screening Europe 2010
Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011
Clinical Trials Utilising Radioactivity in Support of Drug Development Stephen Madden, Head, Metabolism and Pharmacokinetics, Charles River speaking at ADMET Europe 2011
Use of Informatics Approaches in Risk Assessments Sandeep Modi, Cheminformatician, Unilever speaking at ADMET Europe 2011
Drug Metabolism and Toxicity: Influence of Genetic and Epigenetic Factors Magnus Ingelman-Sundberg, Professor and Head of Pharmacogenetics, Karolinska Institutet speaking at ADMET Europe 2011